Individuals Discontinuing Weight-Loss Injections Regain Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

A recent study indicates that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.

Published data in a prominent health publication demonstrates that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying these drugs should be cognizant of the risk of fast weight regain when the medication ends," stated researcher Dr. Susan Jebb.

This pace of recovery means a reversion to original weight within about one and a half years.

Comparing Approaches

The research, which reviewed dozens of studies involving thousands of patients, contrasted the results of these new drugs with other pills.

Scientists note that people who lose weight through dieting usually have a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Fast Rebound

Experts propose the mechanism of the injections accounts for the heightened rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which controls appetite.

"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication results in appetite is uncontrolled, making binge eating a significant risk."

A Chronic Condition?

The NHS suggest the injections for individuals with weight-linked health risks, alongside recommended lifestyle changes.

Professionals contend that, considering the likelihood of relapse, the treatment might need to be ongoing.

This view is reinforced by drug manufacturers, who say that the results "emphasize the persistent nature of excess weight," akin to managing conditions like high blood pressure.

User Experiences

Individuals who have stopped the medication explain a sudden resurgence of appetite.

"I experienced a trigger that goes on and you become starving," described an individual.

The struggle is exacerbated if individuals have not established permanent lifestyle or habit modifications during treatment.

Widespread Interest

Recent estimates show that millions of people in the UK have tried these injections in the past year, with demand continuing to grow.

• Adoption is more common among females compared to males.
• The 40s and 50s age group shows the highest level of interest.
• Many obtain the medications through private healthcare rather than the NHS.

Finally, researchers caution that while the jabs are potent agents for weight loss, they are not a standalone fix and lasting health benefits relies on ongoing behavioural management.